Earlier today, I represented the Union and voiced employee concerns during a town hall meeting held by Associate Commissioner for Regulatory Affairs (ACRA) Mel Plaisier, the head of the FDA Office of Regulatory Affairs (ORA). I also made the most of a 30-minute one-on-one meeting with the ACRA to further discuss employee and Union concerns.
I brought up the many complaints I have heard from employees about the appearance of premature implementation of Program Alignment, the agency’s interpretation of the 14-hour rule for official travel, the Union’s efforts to assist the Agency to attract and retain valuable employees through quality-of-worklife perks that already exist in our collective bargaining agreement (e.g., telework, alternate work schedules, and awards), and my concerns as chapter president about the poor state of labor-management relations between our chapter and ORA Southwest Region management.
Ms. Plaisier appeared to be very receptive and willing to work with the Union. Of course, the proof is in the pudding, and actions are louder than words. Let’s see if the dynamic changes for the better.